| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 医药代理(元) | 169,684,424.42 | 409,405,490.13 | 226,148,427.20 | 440,515,432.12 | 203,253,981.44 |
| 医药技术服务(元) | - | - | - | - | 10,849,056.60 |
| 医药制造(元) | 144,315,840.33 | 246,761,536.98 | 110,037,357.36 | 268,786,820.29 | 180,842,085.06 |
| 医药技术服务及技术转让(元) | 5,906,528.70 | 17,850,956.06 | 10,305,411.81 | 10,866,218.20 | - |
| 营业成本(元) | |||||
| 医药代理(元) | 73,349,575.27 | 184,479,823.93 | 99,312,868.59 | 188,520,321.15 | 87,556,784.88 |
| 医药技术服务(元) | - | - | - | - | 4,055,471.80 |
| 医药制造(元) | 66,614,331.94 | 116,292,928.31 | 54,713,917.06 | 119,685,549.15 | 59,930,238.81 |
| 医药技术服务及技术转让(元) | 507,474.86 | 9,235,368.42 | 5,087,611.32 | 4,072,633.40 | - |
| 毛利(元) | |||||
| 医药代理(元) | 96,334,849.15 | 224,925,666.20 | 126,835,558.61 | 251,995,110.97 | 115,697,196.56 |
| 医药技术服务(元) | - | - | - | - | 6,793,584.80 |
| 医药制造(元) | 77,701,508.39 | 130,468,608.67 | 55,323,440.30 | 149,101,271.14 | 120,911,846.25 |
| 医药技术服务及技术转让(元) | 5,399,053.84 | 8,615,587.64 | 5,217,800.49 | 6,793,584.80 | - |
| 毛利率(%) | |||||
| 医药代理(%) | 56.77 | 54.94 | 56.09 | 57.20 | 56.92 |
| 医药技术服务(%) | - | - | - | - | 62.62 |
| 医药制造(%) | 53.84 | 52.87 | 50.28 | 55.47 | 66.86 |
| 医药技术服务及技术转让(%) | 91.41 | 48.26 | 50.63 | 62.52 | - |
| 收入构成(%) | |||||
| 医药代理(%) | 53.04 | 60.74 | 65.27 | 61.17 | 51.46 |
| 医药技术服务(%) | - | - | - | - | 2.75 |
| 医药制造(%) | 45.11 | 36.61 | 31.76 | 37.32 | 45.79 |
| 医药技术服务及技术转让(%) | 1.85 | 2.65 | 2.97 | 1.51 | - |
| 毛利构成(%) | |||||
| 医药代理(%) | 53.69 | 61.79 | 67.69 | 61.78 | 47.53 |
| 医药技术服务(%) | - | - | - | - | 2.79 |
| 医药制造(%) | 43.30 | 35.84 | 29.53 | 36.55 | 49.68 |
| 医药技术服务及技术转让(%) | 3.01 | 2.37 | 2.78 | 1.67 | - |